Videonystagmography Market Global Report 2026

The videonystagmography market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.09 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising prevalence of vestibular disorders, increasing incidence of dizziness and vertigo cases, growing awareness of balance disorder diagnosis, expanding availability of ENT diagnostic services, increasing adoption of non-invasive diagnostic procedures.

The videonystagmography market size is expected to see strong growth in the next few years. It will grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing demand for advanced vestibular assessment technologies, increasing investments in diagnostic infrastructure, rising adoption of wireless diagnostic systems, expanding geriatric population with balance disorders, increasing establishment of specialized vestibular care centers. Major trends in the forecast period include increasing adoption of non-invasive vestibular diagnostic testing, growing demand for comprehensive balance disorder assessment, rising utilization of infrared eye movement tracking systems, expanding use of videonystagmography in vertigo diagnosis, increasing focus on early detection of vestibular disorders.

The growing preference for non-invasive diagnostics is expected to drive the growth of the videonystagmography market in the coming years. Non-invasive diagnostics are medical diagnostic techniques used to assess, monitor, or identify health conditions without breaking the skin, inserting instruments into the body, or involving surgical procedures. Non-invasive diagnostics are gaining traction as patients and healthcare professionals increasingly seek painless, safer, and more convenient diagnostic approaches. Videonystagmography contributes to non-invasive diagnostics by precisely assessing vestibular and balance disorders using infrared-based eye movement tracking technology without the need for invasive procedures. For instance, in November 2024, according to NHS England, a UK healthcare authority, diagnostic imaging tests in England increased to 47.2 million in 2023/24 from 45.0 million in 2022/23, indicating a 4.8% growth, while MRI scans increased to 4.4 million compared with the previous year, reflecting an 8.1% rise. Therefore, the increasing preference for non-invasive diagnostics is contributing to the expansion of the videonystagmography market.

The increasing prevalence of neurological disorders is expected to drive the growth of the videonystagmography market in the coming years. Neurological disorders are medical conditions that impact the brain, spinal cord, and nervous system, leading to impairments in movement, sensation, cognition, communication, and other neurological functions. The growing global aging population is contributing to the rising occurrence of neurological disorders, as age-related changes in the brain and nervous system increase the likelihood of conditions such as stroke, dementia, and Parkinson’s disease. The increasing occurrence of neurological conditions affecting balance regulation and eye movement control is creating greater demand for videonystagmography (VNG) to precisely evaluate vestibular function, detect eye movement abnormalities, and assist in diagnosis and treatment planning. For instance, in October 2023, according to the National Library of Medicine, a US-based biomedical library, global stroke mortality is expected to reach 9.7 million deaths annually by 2050 if current trends continue. Therefore, the rising incidence of neurological disorders is supporting the growth of the videonystagmography market.

Leading companies operating in the videonystagmography market are focusing on developing advanced solutions, such as wireless infrared eye-tracking architecture, to simplify device setup and enhance clinical workflow. Wireless infrared eye tracking architecture is a system design that uses infrared imaging sensors and wireless communication technologies to capture, process, and transmit eye movement data in real time without requiring physical cable connections between the tracking device and connected systems. For example, in May 2023, Inventis S.r.l., an Italy-based medical diagnostics company, launched the SYNAPSYS VideoScope. The system offers a wireless camera configuration with interchangeable Goggles Flex and Xpress Mask options, supports both wired and wireless operation for greater deployment flexibility, and provides high-resolution infrared eye-movement visualization with seamless integration into the Nystalyze platform for comprehensive vestibular assessment. These capabilities enhance clinician productivity, improve patient comfort, and support more efficient diagnosis of vestibular disorders across hospitals and specialty balance clinics.

Major companies operating in the videonystagmography market report are Interacoustics A/S, Natus Sensory, e3 Diagnostics, Difra S.A., BioMed Jena GmbH, Homoth Medizinelektronik GmbH & Co. KG, Neurosoft, American Institute of Balance (AIB), Inventis S.r.l., Secure Health Inc., Mayo Clinic, Johns Hopkins Medicine, Balanceback AB, Vestibular First, House Institute Foundation, FYZICAL Therapy & Balance Centers, Cleveland Clinic, ZEHNIT Medical Technology, Happersberger Otopront GmbH.

North America was the dominant region in the videonystagmography market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the videonystagmography market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the videonystagmography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.